Overcoming barriers in the pharmacological treatment of anxiety disorders
Overcoming barriers in the pharmacological treatment of anxiety disorders
Anxiety disorders are common, distressing and impairing medical conditions that typically have an early onset and prolonged course, are associated with substantial comorbidity and result in increased use of health services. A range of psychological and pharmacological treatments for patients with anxiety disorders are widely available, but many patients who would be likely to benefit from intervention do not seek medical attention, and others who do present are not recognized by their doctors as having a potentially treatable condition. The overall care of many patients with anxiety disorders who are recognized and treated falls markedly below generally recommended standards. This review explores the many barriers to optimal pharmacological treatment of patients with anxiety disorders and suggests methods by which these obstacles might be overcome.
33-44
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Rafiq, R.
143c6a70-1466-4880-b0e9-e273c31b927e
Talat, B.
d21cd045-f7f7-4062-99dd-d11cc5d55823
2013
Baldwin, D.S.
1beaa192-0ef1-4914-897a-3a49fc2ed15e
Rafiq, R.
143c6a70-1466-4880-b0e9-e273c31b927e
Talat, B.
d21cd045-f7f7-4062-99dd-d11cc5d55823
Baldwin, D.S., Rafiq, R. and Talat, B.
(2013)
Overcoming barriers in the pharmacological treatment of anxiety disorders.
Neuropsychiatry, 3 (1), .
(doi:10.2217/npy.12.73).
Abstract
Anxiety disorders are common, distressing and impairing medical conditions that typically have an early onset and prolonged course, are associated with substantial comorbidity and result in increased use of health services. A range of psychological and pharmacological treatments for patients with anxiety disorders are widely available, but many patients who would be likely to benefit from intervention do not seek medical attention, and others who do present are not recognized by their doctors as having a potentially treatable condition. The overall care of many patients with anxiety disorders who are recognized and treated falls markedly below generally recommended standards. This review explores the many barriers to optimal pharmacological treatment of patients with anxiety disorders and suggests methods by which these obstacles might be overcome.
This record has no associated files available for download.
More information
Published date: 2013
Organisations:
Faculty of Medicine
Identifiers
Local EPrints ID: 367931
URI: http://eprints.soton.ac.uk/id/eprint/367931
ISSN: 1758-2008
PURE UUID: 0c3054cb-034e-403a-9341-b25be8992515
Catalogue record
Date deposited: 09 Sep 2014 12:52
Last modified: 15 Mar 2024 02:49
Export record
Altmetrics
Contributors
Author:
R. Rafiq
Author:
B. Talat
Download statistics
Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.
View more statistics
